Cantel Medical - CMD Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$80.37
+0 (0.00%)
Get New Cantel Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CMD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CMD

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Cantel Medical in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $80.37.

This chart shows the closing price for CMD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Cantel Medical. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/2/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/31/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/25/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/13/2021Needham & Company LLCDowngradeBuy ➝ HoldMedium
1/12/2021SidotiDowngradeBuy ➝ NeutralMedium
12/10/2020SidotiBoost Target$72.00 ➝ $100.00Low
10/23/2020CJS SecuritiesInitiated CoverageOutperform$70.00Low
8/19/2020Bank of AmericaInitiated CoverageUnderperform$51.00High
8/6/2020Needham & Company LLCReiterated RatingBuyN/A
6/4/2020Needham & Company LLCInitiated CoverageBuy$65.00N/A
5/12/2020Needham & Company LLCLower TargetBuy$75.00 ➝ $65.00N/A
4/14/2020SidotiLower TargetBuy$84.00 ➝ $65.00N/A
2/18/2020SidotiLower TargetBuy$116.00 ➝ $108.00N/A
2/11/2020Needham & Company LLCLower TargetBuy$94.00 ➝ $82.00High
12/10/2019Needham & Company LLCReiterated RatingBuy$94.00N/A
11/26/2019Needham & Company LLCUpgradeHold ➝ Buy$94.00N/A
9/24/2019Raymond JamesReiterated RatingHoldN/A
6/11/2019Needham & Company LLCReiterated RatingHoldN/A
(Data available from 4/25/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/28/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/28/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/26/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/26/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/25/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Cantel Medical logo
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.
Read More

Today's Range

Now: $80.37
Low: $80.37
High: $80.37

50 Day Range

MA: $82.48
Low: $80.37
High: $88.79

52 Week Range

Now: $80.37
Low: $39.40
High: $89.76

Volume

N/A

Average Volume

626,604 shs

Market Capitalization

$3.58 billion

P/E Ratio

69.28

Dividend Yield

0.26%

Beta

1.55

Frequently Asked Questions

What sell-side analysts currently cover shares of Cantel Medical?

The following sell-side analysts have issued stock ratings on Cantel Medical in the last twelve months:
View the latest analyst ratings for CMD.

What is the current price target for Cantel Medical?

0 Wall Street analysts have set twelve-month price targets for Cantel Medical in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Cantel Medical in the next year.
View the latest price targets for CMD.

What is the current consensus analyst rating for Cantel Medical?

Cantel Medical currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for CMD.

What other companies compete with Cantel Medical?

How do I contact Cantel Medical's investor relations team?

Cantel Medical's physical mailing address is 150 CLOVE ROAD, LITTLE FALLS NJ, 07424. The company's listed phone number is 973-890-7220 and its investor relations email address is [email protected]. The official website for Cantel Medical is www.cantelmedical.com. Learn More about contacing Cantel Medical investor relations.